V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 140026609 | 140031075 | 1.59 | 96.5 | Curative (C) | 2019-09-05 | 2019-09-19 | Cisplatin + Radiotherapy | 02 | y | CISPLATIN + RT | 101085396 |
| 20223927 | 20132620 | 1.75 | 89.9 | Palliative (P) | 2019-03-19 | 2019-03-19 | Ralitrexed | 01 | y | RALTITREXED | 101522593 |
| 140026904 | 140031268 | 1.59 | 38 | null | 2016-12-10 | 2016-12-10 | NIVOLUMAB | 02 | y | NIVOLUMAB | 101233455 |
| 140027122 | 140031415 | 1.64 | 69 | Curative (C) | 2016-06-08 | 2016-06-08 | Cisplatin + Radiotherapy | N | y | CISPLATIN + RT | 101833342 |
| 140027409 | 140031580 | 1.78 | 66 | Curative (C) | 2019-12-27 | 2020-01-08 | Cisplatin + Radiotherapy | 02 | y | CISPLATIN + RT | 100541634 |
| 140027429 | 140031589 | 1.77 | 72.7 | Curative (C) | 2016-02-26 | 2016-05-30 | Cisplatin + Radiotherapy | 02 | y | CISPLATIN + RT | 100336320 |
| 140027737 | 140031727 | 1.74 | 65.3 | Curative (C) | 2017-04-17 | 2017-05-08 | Cisplatin 100 + RT(H&N) 1 day | 02 | y | CISPLATIN + RT | 100886191 |
| 140023863 | 140036835 | 1.8 | 89.8 | Curative (C) | 2019-10-06 | 2019-12-31 | NIVOLUMAB | 02 | y | NIVOLUMAB | 100856584 |
| 140023966 | 140036847 | 1.63 | null | Curative (C) | 2019-02-27 | 2019-04-03 | Cisplatin + Radiotherapy | N | y | CISPLATIN + RT | 100843783 |
| 140025630 | 140037102 | 1.56 | 80.5 | Adjuvant (A) | 2019-10-16 | 2019-10-17 | CARBOPLATIN + RT | 02 | y | CARBOPLATIN | 101091655 |
| 140025743 | 140040512 | 1.61 | 88.6 | Curative (C) | 2016-12-22 | 2016-12-26 | CISPLATIN + RT | 02 | y | CISPLATIN + RT | 101761881 |
| 140025802 | 140040535 | 1.87 | 94 | Adjuvant (A) | 2017-11-04 | 2017-12-01 | Carboplatin AUC 2 - 5 | 02 | y | CARBOPLATIN | 100944402 |
| 140026024 | 140040591 | 1.87 | 64.8 | Curative (C) | 2017-07-16 | 2017-08-12 | NIVOLUMAB | 02 | y | NIVOLUMAB | 101056121 |
| 140026731 | 140031154 | 1.78 | 77.25 | Curative (C) | 2019-05-16 | 2019-05-24 | NIVOLUMAB | 02 | y | NIVOLUMAB | 101705090 |
| 150012130 | 150006644 | 1.83 | 85.4 | Adjuvant (A) | 2017-07-22 | 2017-08-13 | Temozolomide + RT | 02 | y | TEMOZOLOMIDE | 101847995 |
| 150017775 | 150009468 | 0 | 30 | Palliative (P) | 2016-10-15 | 2016-11-04 | Temozolomide + RT | 02 | y | TRIAL | 100272756 |
| 250001268 | 250004718 | 1.56 | 102.2 | Curative (C) | 2017-11-26 | 2018-01-14 | NB HRNBL-1 Isotretinoin | 02 | y | CAPECITABINE + OXALIPLATIN | 100064176 |
| 250002003 | 250005813 | null | null | null | 2018-07-07 | 2018-07-09 | BEP 5 Day | 02 | y | DOXORUBICIN | 100155505 |
| 50110321 | 50016903 | 0.1 | 63.8 | Palliative (P) | 2016-11-20 | 2016-11-21 | null | 02 | y | PEMBROLIZUMAB | 100302160 |
| 50141684 | 50018013 | 1.71 | 62.7 | Palliative (P) | 2018-01-27 | 2018-02-06 | Ribociclib | N | y | OXALIPLATIN + MDG | 101532838 |
| 60101992 | 60038127 | 1.8 | 64.6 | Palliative (P) | null | 2020-03-10 | Carboplatin + Pemetrexed | 2 | y | CARBOPLATIN + PEMETREXED | 101416642 |
| 10412813 | 10041184 | 1.83 | 85.3 | Curative (C) | null | 2018-02-20 | AVELUMAB + AXITINIB | N | y | DOXORUBICIN EMBOLISATION | 101402022 |
| 10454916 | 10042095 | null | null | Curative (C) | 2019-07-01 | 2019-07-03 | AVELUMAB + AXITINIB | 02 | y | RIALTO TRIAL | 101332640 |
| 20088443 | 20025288 | 1.65 | 47.3 | Curative (C) | 2016-12-15 | 2016-12-26 | Capecitabine | 02 | y | CAPECITABINE | 100355505 |
| 20210368 | 20078298 | 1.76 | 62.6 | Curative (C) | 2018-10-12 | 2018-10-21 | CISPLATIN + FLUOROURACIL | 02 | y | CISPLATIN + FLUOROURACIL | 101177350 |
| 20212452 | 20079082 | 1.68 | 80 | Adjuvant (A) | 2018-06-22 | 2018-07-05 | CAPECITABINE + CARBOPLATIN | 02 | y | CISPLATIN + FLUOROURACIL | 100102989 |
| 20220923 | 20084129 | 0 | 78.3 | null | 2018-10-28 | 2018-11-01 | Enzalutamide | null | y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100021300 |
| 20205126 | 20127319 | 1.56 | 91.4 | Adjuvant (A) | 2019-07-04 | 2019-07-26 | GEMCITABINE + NAB PACLITAXEL | 02 | y | GEMCITABINE + NAB-PACLITAXEL | 100224569 |
| 20205545 | 20127408 | 1.73 | 46.4 | Neo-adjuvant (N) | 2017-09-05 | 2017-09-12 | GEMCITABINE + NAB PACLITAXEL | 02 | y | GEMCITABINE + NAB-PACLITAXEL | 100794463 |
| 20206349 | 20127560 | 1.68 | 64.2 | 03 | 2016-01-18 | 2016-05-23 | GEMCITABINE + NAB PACLITAXEL | 02 | y | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100871943 |
| 20208695 | 20128008 | 1.76 | 57 | Curative (C) | 2014-08-28 | 2015-11-23 | HCX | 02 | y | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101813824 |
| 20214843 | 20130091 | 1.69 | 62.9 | null | 2014-06-04 | 2014-06-21 | Cetuximab + FOLFIRI cycle 2 onwards | N | y | EOX | 100155282 |
| 20217995 | 20131514 | null | null | Curative (C) | null | 2018-08-08 | CARBOPLATIN + GEMCITABINE | 02 | y | CARBOPLATIN + GEMCITABINE | 100770145 |
| 20218787 | 20131721 | null | null | Palliative (P) | 2020-02-16 | 2020-02-16 | CAPECITABINE + TEMOZOLOMIDE | 02 | y | CAPECITABINE + TEMOZOLOMIDE | 100237092 |
| 20219072 | 20131793 | 0 | 54.5 | Curative (C) | null | 2019-06-17 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | y | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100153605 |
| 20219303 | 20131847 | 1.71 | 53.7 | Adjuvant (A) | 2018-08-06 | 2018-11-09 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | y | FLUOROURACIL + MITOMYCIN + RT | 101309556 |
| 20221110 | 20132233 | 1.72 | 80.2 | Curative (C) | 2019-02-16 | 2019-02-20 | null | null | y | RALTITREXED | 101718312 |
| 20221836 | 20132321 | 1.63 | 49 | Palliative (P) | null | 2017-10-01 | null | null | y | PLATFORM TRIAL | 101338877 |
| 30087153 | 30118334 | 1.69 | 71.6 | Adjuvant (A) | 2017-11-19 | 2017-11-19 | TOPOTECAN | 02 | y | TEMOZOLOMIDE | 100103167 |
| 20225082 | 20132765 | 1.51 | 60.6 | null | 2020-07-02 | 2020-07-14 | null | 01 | y | MITOMYCIN INTRAVESICULAR | 100306348 |
| 80008552 | 80043843 | 1.87 | 18.3 | null | 2019-01-10 | 2020-05-06 | Palbociclib | 01 | y | ATEZOLIZUMAB + CARBOPLATIN + ETOPOSIDE | 100968467 |
| 80060141 | 80051404 | 0 | 77.8 | null | 2018-09-19 | 2018-09-26 | WT Guidelines Carboplatin/Etoposide | 01 | y | WT SIOP 2002 01 POST OP VADVV | 100545010 |
| 90027446 | 90032189 | 1.62 | null | Disease modification (D) | 2019-02-26 | 2019-03-04 | Bevacizumab+Carbo+Pacliaxel | Y | y | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100375370 |
| 20212394 | 20154554 | 1.76 | 69 | Palliative (P) | 2017-04-19 | 2017-09-01 | GEMCITABINE + NAB PACLITAXEL | 02 | y | CAPECITABINE + CARBOPLATIN | 101367110 |
| 20212790 | 20154681 | 1.56 | 48 | Palliative (P) | 2021-05-31 | 2021-10-06 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | y | GEMCITABINE + NAB-PACLITAXEL | 100628859 |
| 20221621 | 20156658 | 1.69 | 55 | Curative (C) | 2016-09-05 | 2016-09-05 | REGORAFENIB | 02 | y | REGORAFENIB | 100600728 |
| 20214698 | 20168292 | 1.85 | 77 | Curative (C) | 2017-06-14 | 2017-06-17 | ECX | 02 | y | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101735652 |
| 20214763 | 20168303 | 1.7 | 39 | Curative (C) | 2018-07-15 | 2018-10-09 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | y | CAPECITABINE + CARBOPLATIN | 101470973 |
| 20216338 | 20175044 | null | 48.1 | Palliative (P) | 2021-10-01 | 2022-04-30 | ECX | 02 | y | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100013830 |
| 150011768 | 150006442 | 1.6 | 56 | Palliative (P) | 2019-01-06 | 2019-02-03 | TEMOZOLOMIDE | N | y | TEMOZOLOMIDE | 100456138 |